Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be commonly prescribed for depression, urinary incontinence, irritable bowel syndrome and Parkinson's disease. Challenges in safely deprescribing common anticholinergic drugs
Aucun commentaire:
Enregistrer un commentaire